These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 25879528

  • 41. Metformin diminishes the unfavourable impact of Nrf2 in breast cancer patients with type 2 diabetes.
    Urpilainen E, Kangaskokko J, Puistola U, Karihtala P.
    Tumour Biol; 2019 Jan; 41(1):1010428318815413. PubMed ID: 30803422
    [Abstract] [Full Text] [Related]

  • 42. CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients.
    Li Z, Chen K, Jiang P, Zhang X, Li X, Li Z.
    Diagn Pathol; 2014 Apr 08; 9():79. PubMed ID: 24708709
    [Abstract] [Full Text] [Related]

  • 43. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
    Cai L, Cai X.
    Diagn Pathol; 2014 Dec 31; 9():1000. PubMed ID: 25552204
    [Abstract] [Full Text] [Related]

  • 44. Proteins of the retinoblastoma pathway, FEN1 and MGMT are novel potential prognostic biomarkers in pancreatic adenocarcinoma.
    Isohookana J, Haapasaari KM, Soini Y, Leppänen J, Karihtala P.
    Pathol Res Pract; 2018 Jun 31; 214(6):840-847. PubMed ID: 29735403
    [Abstract] [Full Text] [Related]

  • 45. Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy.
    Lister A, Nedjadi T, Kitteringham NR, Campbell F, Costello E, Lloyd B, Copple IM, Williams S, Owen A, Neoptolemos JP, Goldring CE, Park BK.
    Mol Cancer; 2011 Apr 13; 10():37. PubMed ID: 21489257
    [Abstract] [Full Text] [Related]

  • 46. High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer patients.
    Leppänen J, Helminen O, Huhta H, Kauppila JH, Isohookana J, Haapasaari KM, Lehenkari P, Saarnio J, Karttunen TJ.
    Virchows Arch; 2017 Apr 13; 470(4):401-410. PubMed ID: 28191612
    [Abstract] [Full Text] [Related]

  • 47. Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis.
    Stępkowski TM, Kruszewski MK.
    Free Radic Biol Med; 2011 May 01; 50(9):1186-95. PubMed ID: 21295136
    [Abstract] [Full Text] [Related]

  • 48. Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer.
    Juuti A, Louhimo J, Nordling S, Ristimäki A, Haglund C.
    J Clin Pathol; 2006 Apr 01; 59(4):382-6. PubMed ID: 16467169
    [Abstract] [Full Text] [Related]

  • 49. Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction.
    Sun L, Chen F, Shi W, Qi L, Zhao Z, Zhang J.
    Diagn Pathol; 2014 Jul 16; 9():125. PubMed ID: 25029906
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Expression of CD44 in pancreatic cancer and its significance.
    Li XP, Zhang XW, Zheng LZ, Guo WJ.
    Int J Clin Exp Pathol; 2015 Jul 16; 8(6):6724-31. PubMed ID: 26261555
    [Abstract] [Full Text] [Related]

  • 53. Partner of Sld five 3: a potential prognostic biomarker for colorectal cancer.
    Sun X, Sui W, Huang M, Wang Y, Xuan Y, Wang Z.
    Diagn Pathol; 2014 Nov 18; 9():217. PubMed ID: 25403684
    [Abstract] [Full Text] [Related]

  • 54. Tumor budding is an independent adverse prognostic factor in pancreatic ductal adenocarcinoma.
    O'Connor K, Li-Chang HH, Kalloger SE, Peixoto RD, Webber DL, Owen DA, Driman DK, Kirsch R, Serra S, Scudamore CH, Renouf DJ, Schaeffer DF.
    Am J Surg Pathol; 2015 Apr 18; 39(4):472-8. PubMed ID: 25634751
    [Abstract] [Full Text] [Related]

  • 55. Overexpression of her-2 associated with the progression of esophageal cancer patients.
    Wang G, Zhang W, Jiang W, Luan L.
    Hepatogastroenterology; 2013 Apr 18; 60(128):1972-8. PubMed ID: 24719937
    [Abstract] [Full Text] [Related]

  • 56. Expression and prognostic value of c-Myc and Fas (CD95/APO1) in patients with pancreatic cancer.
    He C, Jiang H, Geng S, Sheng H, Shen X, Zhang X, Zhu S, Chen X, Yang C, Gao H.
    Int J Clin Exp Pathol; 2014 Apr 18; 7(2):742-50. PubMed ID: 24551298
    [Abstract] [Full Text] [Related]

  • 57. Prognostic value and clinicopathological features of PD-1/PD-L1 expression with mismatch repair status and desmoplastic stroma in Chinese patients with pancreatic cancer.
    Wang Y, Lin J, Cui J, Han T, Jiao F, Meng Z, Wang L.
    Oncotarget; 2017 Feb 07; 8(6):9354-9365. PubMed ID: 28030840
    [Abstract] [Full Text] [Related]

  • 58. Reduced MUTYH, MTH1, and OGG1 expression and TP53 mutation in diffuse-type adenocarcinoma of gastric cardia.
    Kohno Y, Yamamoto H, Hirahashi M, Kumagae Y, Nakamura M, Oki E, Oda Y.
    Hum Pathol; 2016 Jun 07; 52():145-52. PubMed ID: 26980051
    [Abstract] [Full Text] [Related]

  • 59. Insights into the prognostic value of DJ-1 and MIB-1 in astrocytic tumors.
    Abd El Atti RM, Abou Gabal HH, Osman WM, Saad AS.
    Diagn Pathol; 2013 Jul 31; 8():126. PubMed ID: 23902708
    [Abstract] [Full Text] [Related]

  • 60. Expression of Tiam1 predicts lymph node metastasis and poor survival of lung adenocarcinoma patients.
    Liu S, Li Y, Qi W, Zhao Y, Huang A, Sheng W, Lei B, Lin P, Zhu H, Li W, Shen H.
    Diagn Pathol; 2014 Mar 24; 9():69. PubMed ID: 24661909
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.